Click link below picture
.
A second new personalized treatment for cancer has won approval from the Food and Drug Administration — a clear sign that such treatments will become more widely available for patients with no other options.
The treatment is called CAR-T and can have dramatic effects in some patients. But it is both grueling and expensive and will remain a last-ditch treatment for a few, specific cancer types.
The company that will market it, Gilead Sciences, has priced it at $373,000 and the FDA warns it can cause severe side effects.
.
Cell therapy specialists prepare blood cells from a patient to be engineered in the lab to fight cancer at Kite Pharma, the company that developed the Yescarta therapy, in El Segundo, California. Kite Pharma via AP
.
.
Click link below for article:
https://www.nbcnews.com/health/health-news/fda-approves-second-personalized-therapy-cancer-n812241
.
__________________________________________
James' World 2 
Leave a comment